Gentler approach tested to protect older cancer patients from transplant complications
NCT ID NCT05622318
Summary
This study is testing whether a lower-dose combination of medications can safely prevent graft-versus-host disease (GVHD) in older adults receiving stem cell transplants for blood cancers. GVHD occurs when donor immune cells attack the patient's body, and current prevention methods can have significant side effects. The trial will enroll 56 patients to see if this modified approach reduces severe GVHD while maintaining transplant effectiveness.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GRAFT -VERSUS-HOST-DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Froedtert Hospital & the Medical College of Wisconsin
Milwaukee, Wisconsin, 53226, United States
Conditions
Explore the condition pages connected to this study.